By submitting this form, you are consenting to receive marketing emails from: Sickle Cell Disease Association of America, 3700 Koppers Street, Suite 570, Baltimore, MD, 21227, US, http://sicklecelldisease.org. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact.
Sickle Cell News
- ASH and FDA Unveil New Recommendations to Guide Clinical Development of Sickle Cell Disease Therapies December 13, 2019
- GBT’s Oxbryta™ (voxelotor) tablets is approved for the treatment of sickle cell disease December 3, 2019
- New Hope for a Sickle Cell Cure December 2, 2019
- FDA Approves Global Blood Therapeutics Sickle Cell Disease Drug November 26, 2019
- CRISPR Therapeutics and Vertex Announce Positive Safety and Efficacy Data November 19, 2019